Agah Ramtin 4
4 · RenovoRx, Inc. · Filed Dec 17, 2025
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Agah Ramtin
DirectorChief Medical Officer
Transactions
- Purchase
Common Stock
2025-12-16$0.85/sh+12,000$10,200→ 778,460 total
Footnotes (1)
- [F1]Reflects an open market purchase of the Issuer's securities.